Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study to Find Maintenance Dose for Periodic Administration of ASP3550

This study has been completed.
Information provided by (Responsible Party):
Astellas Pharma Inc Identifier:
First received: December 1, 2010
Last updated: July 8, 2013
Last verified: July 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2012
  Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)